The 4-Day Change in Mental Status: Delirium, Not Aging

Anchor concept: an acute, fluctuating change in attention and awareness over 4 days is delirium until proven otherwise. Delirium is a syndrome, not a diagnosis - the clinical work is finding the trigger. Age alone never explains a sharp 4-day change, so the daughter's framing must be gently corrected.

History priorities, in this order:

• Collateral first, patient second. Interview the daughter alone for baseline cognition, ADLs, prior episodes, and any fall or head strike. A patient who is oriented to person/place can still have inattention.
• Bottles-in-hand medication review. The recent ibuprofen addition is the highest-yield finding: NSAID plus warfarin produces GI blood loss and raises INR; NSAIDs also cause AKI and hyperkalemia. Zolpidem in an older adult is a well-recognized delirium and fall trigger. Metoprolol plus volume loss explains the low sitting pressure.
• Screen the common trigger clusters: infection, medication, metabolic derangement, pain/constipation/urinary retention, and organ events (MI, stroke, hemorrhage).
• Substance use: alcohol intake, withdrawal risk, and any sedative use not on the list.

Exam priorities: volume status, orthostatics (done), guaiac/rectal exam, skin for bruising, lung and cardiac exam for new murmur or arrhythmia, abdomen, a focal neuro exam, gait, and a formal arousal/attention tool (4AT or CAM) documented in the note.

Reasoning: the exam is directed at which findings change disposition today - hypoxia, fever, focal deficit, melena, or a new irregular rate at 130 means emergency department transfer now, not an office workup.

The numbers: sitting 104/62 to standing 92/58 at 1 minute is a 12 mm Hg systolic and 4 mm Hg diastolic fall. That does not meet the consensus threshold for orthostatic hypotension (sustained drop of at least 20 systolic or 10 diastolic within 3 minutes of standing). So the label 'orthostatic hypotension' is not earned yet - but the vital signs are still clinically meaningful.

Why the label matters: in a patient on metoprolol with a 2 kg weight loss and poor intake, a systolic pressure falling into the low 90s is a marker of reduced physiologic reserve. It explains the unsteady gait and the fall risk, and it may be a consequence of the same process causing the delirium. It is not the cause of the delirium itself - treating 'orthostasis' and sending her home misses the point.

Confounders and alternatives to exclude:

• Technique: was she standing long enough, arm supported, correct cuff size, measured after positional change rather than after walking?
• Rate-related hypotension from atrial fibrillation with variable ventricular response - check a rhythm strip and rate trend.
• Drug effect: metoprolol dose, plus any prn antihypertensive; sedative effect of zolpidem.
• Volume depletion from poor intake, fever, or GI losses - corroborate with mucous membranes, skin turgor, BUN/creatinine ratio, and urine output history.
• Autonomic neuropathy and deconditioning in a patient who has been sitting more due to knee pain.
• Anemia from NSAID-related blood loss, which produces both the pressure drop and the cognitive change.

Practical synthesis: treat the vital signs as data pointing toward a medication-and-volume problem, and let the CBC, INR, renal function, and glucose confirm or refute it. Recheck pressures after any fluid and after holding the offending agents.

Ranked hypotheses:

1. Medication-related adverse event (most likely). Ibuprofen started 10 days ago on a background of warfarin, zolpidem, and metoprolol. NSAID plus anticoagulant gives a plausible bleeding source; zolpidem gives a plausible direct delirium. The timing fits precisely.
2. Occult GI blood loss / anemia. Strongly linked to hypothesis 1 rather than separate from it - melena, dizziness, tachycardia, and a 2 kg weight loss all fit.
3. Infection (urinary or respiratory). Common, but be careful: a positive urinalysis in an older adult without urinary symptoms is frequently asymptomatic bacteriuria and should not be treated or accepted as the delirium explanation.
4. Metabolic/renal: AKI from NSAID plus dehydration, hyperkalemia, hyponatremia, hypercalcemia, or dysglycemia.
5. Acute cerebrovascular event or new arrhythmia. Lower probability without focal findings, but the consequence of missing it is high.

Single most management-changing test: bedside point-of-care glucose first, because it is immediate, free of harm, and a reversible cause that must be excluded in any acute confusional state. If glucose is normal, the test that actually reorders today's plan is a CBC with INR drawn together - a hemoglobin of 7.5 with an INR of 6.0 from the NSAID-warfarin interaction converts this from an office visit into same-day emergency evaluation with warfarin held and reversal considered.

Justification for the pairing: the pretest probability of bleeding is high enough that a reassuring INR alone would not be sufficient, and a reassuring hemoglobin alone would not tell you whether anticoagulation must be held. Also send BMP (renal function, potassium, sodium), urinalysis only if urinary symptoms, ECG, and a chest film if hypoxia or focal lung findings.

Disposition threshold: if hemoglobin is significantly below baseline, INR is supratherapeutic, there is melena, or a focal deficit appears - emergency transfer. If all are reassuring and the delirium tracks to zolpidem plus dehydration, stop zolpidem and ibuprofen, arrange supervised hydration with daily check-ins, and reassess within 24-48 hours in person.